Evidence map›Paper›PMID 16439562›Full record

ArticleJournal of virology2006

Identification of spliced gammaherpesvirus 68 LANA and v-cyclin transcripts and analysis of their expression in vivo during latent infection.

Robert D Allen, Shelley Dickerson, Samuel H Speck

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Journal of virology · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Robert D AllenCenter for Emerging Infectious Diseases, Yerkes National Primate Research Center, Emory University School of Medicine, 954 Gatewood Rd., NE, Atlanta, GA 30329, USA. sspeck@rmy.emory.edu
Shelley Dickerson
Samuel H Speck
Emory University · US

Funding

YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
Role of B Cells in Murine Gammaherpesvirus-68 LatencyR01CA095318 · NCI · EMORY UNIVERSITY · PI SCHARER, CHRISTOPHER D · 2003 to 2019
$4.9M
Control of Gammaherpesvirus ReplicationR01CA052004 · NCI · WASHINGTON UNIVERSITY · PI SPECK, SAMUEL H · 1990 to 2013
$4.1M
CHARACTERIZATION OF THE GAMMA HV68 V CYCLINR01CA087650 · NCI · WASHINGTON UNIVERSITY · PI SPECK, SAMUEL H · 2000 to 2011
$3.2M
VIRAL TRANSCRIPTION IN EBV TRANSFORMED HUMAN B CELLSR01CA043143 · NCI · WASHINGTON UNIVERSITY · PI SPECK, SAMUEL H · 1986 to 2006
$1.7M
NCI NIH HHS CA52004NCI NIH HHS CA87650NCI NIH HHS CA95318NCI NIH HHS R01 CA043143NCI NIH HHS R01 CA052004NCI NIH HHS R01 CA087650NCI NIH HHS R01 CA095318NCI NIH HHS R01 CA43143NCRR NIH HHS P51 RR000165NCRR NIH HHS P51 RR00165NIAID NIH HHS AI59057
6 · The paper itself

Abstract

Regulation of orf73 (LANA) gene expression is critical to the establishment and maintenance of latency following infection by members of the gamma-2 herpesvirus (rhadinovirus) family. Previous studies of murine gammaherpesvirus 68 (gammaHV68) have demonstrated that loss of LANA function results in a complete failure to establish virus latency in the spleens of laboratory mice. Here we report the characterization of alternatively spliced LANA and v-cyclin (orf72) transcripts encoded by gammaHV68. Similar to other rhadinoviruses, alternative splicing, coupled with alternative 3' processing, of a ca. 16-kb transcriptional unit can lead to expression of either LANA or v-cyclin during gammaHV68 infection. Spliced LANA and v-cyclin transcripts were initially identified from an analysis of the gammaHV68 latently infected B-cell lymphoma cell line S11E, but were also detected during lytic infection of NIH 3T12 fibroblasts. 5' Random amplification of cDNA ends (RACE) analyses identified two distinct promoters, p1 and p2, that drive expression of spliced LANA transcripts. Analysis of p1 and p2, using transiently transfected reporter constructs, mapped the minimal sequences required for promoter activity and demonstrated that both promoters are active in the absence of any viral antigens. Analysis of spliced LANA and v-cyclin transcripts in spleens recovered from latently infected mice at days 16 and 42 postinfection revealed that spliced v-cyclin transcripts can only be detected sporadically, suggesting that these may be associated with cells reactivating from latency. In contrast, spliced LANA transcripts were detected in ca. 1 in 4,000 splenocytes harvested at day 16 postinfection. Notably, based on the frequency of viral genome-positive splenocytes at day 16 postinfection (ca. 1 in 200), only 5 to 10% of viral genome-positive splenocytes express LANA. The failure of the majority of infected splenocytes at day 16 postinfection to express LANA may contribute to the contraction in the frequency of latently infected splenocytes as chronic infection is established, due to failure to maintain the viral episome in proliferating B cells.

Indexed as

Alternative SplicingVirus LatencyAnimalsAntigens, ViralBase SequenceCell Line, TumorCells, CulturedCyclinsGammaherpesvirinaeHerpesviridae InfectionsMiceModels, AnimalMolecular Sequence DataNuclear ProteinsPromoter Regions, GeneticReverse Transcriptase Polymerase Chain ReactionAntigens, ViralCyclinslatency-associated nuclear antigenM cyclin, gamma-herpesvirus 68Nuclear ProteinsRNA, MessengerRNA, ViralViral Proteins

Identifiers

PMID16439562
PMCPMC1367133
OpenAlexW1983354423

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.